Rituximab added to CHOP chemotherapy shows promise as a treatment for HIV-associated non-Hodgkin's lymphoma (NHL)

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1551, 2006-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

IMMU 106 shows promise in non-Hodgkin's lymphoma

Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

An Evaluation of the Cost-Effectiveness of Rituximab in Combination with Chemotherapy for the First-Line Treatment of Follicular Non-Hodgkin's Lymphoma in the UK

By Ray Joshua A. Carr Emma Lewis Gavin Marcus Robert

Value in Health, Vol. 13, Iss. 4, 2010-06 ,pp. : 346-357

Blackwell Publishing

Access to resources Recommend Favorite

Treatment of AIDS Related Non-Hodgkin's Lymphoma with Combination Mitoguazone Dihydrochloride and Low Dose Chop Chemotherapy: Results of a Phase II study

By Tulpule Anil Espina Byron M. Pedro Santabarbara A. B. Palmer Maria Schiflett Joanne Boswell William Smith Susan Levine Alexandra M.

Investigational New Drugs, Vol. 22, Iss. 1, 2004-01 ,pp. : 63-68

Springer Publishing Company

Access to resources Recommend Favorite

Rituximab for the Treatment of Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukaemia

By Hagemeister Fredrick

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 261-272

Adis International

Access to resources Recommend Favorite

Dose-intensified CHOP ± etoposide in non-Hodgkin's lymphoma

Inpharma, Vol. 1, Iss. 1455, 2004-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite